Adeno-associated Virus Vector class drugs
1 result
Luxturna (voretigene neparvovec-rzyl)
(voretigene neparvovec-rzyl)Spark Therapeutics, Inc.
Usage: LUXTURNA (voretigene neparvovec-rzyl) is a gene therapy indicated for patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy, provided they have viable retinal cells as assessed by their physician.